CH0210483332 (CH0210483332)
Quantitative Summary
DeterministicFinancial health metrics are strong: Piotroski 8/9, Altman Z 4.6 (above 3.0 safe zone threshold).
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe company demonstrates robust fundamental quality, evidenced by a Piotroski F-Score of 8/9 and an Altman Z-Score of 4.6, which collectively signal strong financial health and low bankruptcy risk. While the ROIC-WACC spread sits at +1.6%, indicating value creation above the cost of capital, the DuPont decomposition reveals that high profitability is driven primarily by a substantial gross margin of 66.9% rather than operational leverage or asset turnover; this is further underscored by a net margin of 12.9%. However, revenue growth remains modest at 3.8% year-over-year, suggesting that current earnings power relies heavily on pricing strength and cost control rather than top-line expansion, creating a profile typical of mature or niche businesses where efficiency outweighs scale for value generation.
Valuation metrics present a mixed picture relative to historical norms and sector peers. The current P/E ratio of 22.9x implies the market is pricing in expectations that exceed the company's realized growth rate of 3.8%, potentially compressing multiples if future performance does not accelerate. Conversely, the DCF model calculates a fair value of $57, which serves as an anchor for intrinsic worth independent of multiple expansion assumptions; this suggests the current price may be either fairly valued or slightly elevated depending on whether implied growth rates align with the conservative revenue trajectory provided. The divergence between the high margin profile and low-growth reality necessitates scrutiny of how much premium investors are willing to pay for durability versus scalability in the absence of sector context.
No specific risk factor deltas, insider transaction data, or Fama-French alpha metrics were supplied to refine the risk-reward assessment beyond the static financial scores already analyzed. Consequently, while the balance sheet and profitability indicators remain resilient, the limited revenue growth combined with a P/E multiple that may be stretched relative to its actual expansion rate warrants caution regarding future valuation sustainability absent further catalysts for top-line acceleration.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
DCF Sandbox
InteractiveSensitivity Matrix
| TG ↓ / WACC → | 9% | 11% | 13% |
|---|---|---|---|
| 2% | $66 | $53 | $45 |
| 3% | $73 | $57 | $47 |
| 4% | $84 | $62 | $50 |
Center = base case. Green = >10% upside, Red = >10% downside vs —.
Pre-computed DCF: WACC=11.0%, terminal growth 3%. Fair value $57 (+0.0%). Not investment advice.
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
✅ Conservative payout — room for dividend increases.
Balance Sheet Health
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like EFA or IEFA, the fund manager is mechanically forced to buy or sell CH0210483332 shares regardless of CH0210483332's individual fundamentals. We estimate $1.4B of passive capital is structurally linked to CH0210483332 through 6 tracked ETFs. Index rebalances and ETF creation/redemption cycles can create noticeable volume spikes unrelated to company news.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in CH0210483332 to visualize passive redemption contagion across ETFs and collateral stocks.
If CH0210483332 (CH0210483332) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies ASML Holding N.V. (NL0010273215) as the most exposed collateral stock, sharing 3 ETFs with CH0210483332. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
CH0210483332 Ownership Dynamics
ETFs with Highest CH0210483332 Exposure
Float lock-up computed from 6 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
CH0210483332 Capital Efficiency
How efficiently does CH0210483332 convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.
CH0210483332 converts 50% of its EBITDA into free cash flow, a healthy conversion rate indicating efficient capital management — the business generates substantial cash after reinvestment. The 50% reinvestment rate signals aggressive capacity expansion. The positive ROIC-WACC spread of 1.6% confirms that reinvested capital creates shareholder value.
Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.
Compare CH0210483332 to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.